Vera Therapeutics Inc Class A VERA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $26.20
- Day Range
- $25.34–26.55
- 52-Week Range
- $25.34–56.05
- Bid/Ask
- $10.68 / $26.33
- Shares Outstanding
- 72.30M
- Market Cap
- $1.85B
- Volume/Avg
- 1,065 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 174.90
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 362
- Website
- https://www.veratx.com
Valuation
Metric | VERA |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.55 |
Price/Sales | 174.90 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | VERA |
|---|---|
Quick Ratio | 7.15 |
Current Ratio | 7.91 |
Interest Coverage | −57.66 |
Quick Ratio
VERA
Profitability
Metric | VERA |
|---|---|
Return on Assets (Normalized) | −62.58% |
Return on Equity (Normalized) | −80.11% |
Return on Invested Capital (Normalized) | −71.06% |
Return on Assets
VERA
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|&#X$%D | LOCK|<v?w | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|?b#yjY | LOCK|<c>!x | $98B | |||
| Moderna Inc MRNA | LOCK|s>wM^&K | LOCK|#t? | $80B | |||
| argenx SE ADR ARGX | LOCK|n$L%X^! | LOCK|!d | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|%DT@T@ | LOCK|pXp | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|Z>@r$PKv | LOCK|!n^f | $31B | |||
| Incyte Corp INCY | LOCK|Bf&#N$ | LOCK|<t | $24B | |||
| BioNTech SE ADR BNTX | LOCK|%@P!gD | LOCK|x?& | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|nM?&@p | LOCK|!%S# | $20B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|BZc$>gJ | LOCK|>& | $16B |